over-the-counter

Johnson & Johnson Earnings Up, but Recalls Cut Guidance

Johnson & Johnson's earnings for the second quarter of 2010 rose 5.4% to $3.4 billion, or $1.23 per share, from $3.2 billion or $1.15 per share, the company announced Tuesday morning. Adjusted earnings, which exclude litigation costs, were $1.21 per share.

McNeil Expands Recall of Tylenol, Motrin, Benadryl

Johnson & Johnson subsidiary McNeil recalled another batch of over-the-counter medicines Thursday. The specific lots of Tylenol, Motrin and Benadryl products may have been contaminated with trace amounts of a chemical that gives them a musty or moldy odor.